Relation between Hemoconcentration Status and Readmission Plus Mortality Rate Among Iranian Individuals with

Ashkan Yadollahi Farsani1, Mehrbod Vakhshoori2, Asieh Mansouri3

  • 1Heart Failure Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Hemoconcentration (HC) may be a biomarker for heart failure (HF) risk. While not significantly impacting rehospitalization, HC showed a trend towards lower mortality in acute HF patients.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Hemoconcentration (HC) is a potential biomarker for optimizing diuretic therapy in acute heart failure (HF).
  • The association between HC and rehospitalization or mortality in HF patients remains debated.
  • This study investigated the relationship between HC and readmission/mortality rates in Iranian acute HF patients.

Purpose of the Study:

  • To determine the association between hemoconcentration (HC) and rehospitalization and mortality rates in acute heart failure (HF) patients.
  • To evaluate HC as a potential biomarker for risk stratification in HF management.

Main Methods:

  • Prospective cohort study (March 2017-March 2018) using data from the Persian Registry Of cardioVascular diseasE.
  • Included 390 adult patients with acute HF; 69 exhibited hemoconcentration (increased hemoglobin levels during hospitalization).
  • Analyzed the relationship between HC and readmission/mortality using logistic regression and Cox proportional hazard models.

Main Results:

  • The study population (n=390) had a mean age of 70.5 years, with 66.9% males.
  • Patients with HC did not show a significant difference in rehospitalization rates compared to those without HC.
  • Patients with HC exhibited a borderline significant lower likelihood of mortality (HR 0.82, P=0.08).

Conclusions:

  • Hemoconcentration (HC) is marginally associated with reduced 6-month mortality post-acute heart failure (HF).
  • HC may serve as a useful biomarker for risk stratification in HF patients.
  • Further prospective, population-based studies are needed to confirm these findings.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
96
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
174
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
115
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
144
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
304